COMMUNIQUÉS West-GlobeNewswire
-
ApolloMD Announces Exclusive Professional Liability Solution with The Doctors Company
02/04/2026 -
EssilorLuxottica acquires a stake in Top Charoen, reinforcing its presence in Thailand
02/04/2026 -
Curonix LLC Announces Expanded Reimbursement Coverage for Freedom® Peripheral Nerve Stimulator (PNS) System, Providing Access To An Additional 27 Million Covered Lives Nationwide
02/04/2026 -
EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME)
02/04/2026 -
Liv Hospital Highlights Hospital-Based Stem Cell Infrastructure During Autism Awareness Month
02/04/2026 -
GENFIT Reports Full-Year 2025 Financial Results and Provides Corporate Update
02/04/2026 -
Visory Health Ranks Among Top U.S. Prescription Cards Providing Millions of Americans Access to Affordable Medications
02/04/2026 -
AbbVie IBD Scholarship Program Marks 15 Years: Applications Open for 2026
02/04/2026 -
Medicana Health Group Marks World Autism Awareness Day with a Call for Inclusion, Earlier Recognition and Family-Centered Support
02/04/2026 -
EssilorLuxottica entre au capital de Top Charoen pour renforcer sa présence en Thailande
02/04/2026 -
BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure
02/04/2026 -
GENFIT : Résultats financiers annuels 2025 et point sur les activités de la Société
02/04/2026 -
Le programme de bourses d'études MII d’AbbVie fête ses 15 ans : les candidatures sont ouvertes pour 2026
02/04/2026 -
Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium
02/04/2026 -
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/04/2026 -
Calidi Biotherapeutics to Present New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026
02/04/2026 -
Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer
02/04/2026 -
Catheter Precision Engages Strategic Advisor
02/04/2026 -
Picard Medical / SynCardia COO to Deliver Keynote at Venture Café Phoenix During Arizona Tech Week
02/04/2026
Pages